• By Dana Sparks

Applying Regenerative Medicine to Battlefield Injuries

September 30, 2013

Mayo Clinic researchers are part of the second phase of a national consortium that focuses on developing innovative medical treatments for wounded veterans. Mayo’s role will emphasize peripheral nerve regeneration. Mayo’s principal investigator is Anthony Windebank, M.D., a neurologist and deputy director for discovery in the Mayo Clinic Center for Regenerative Medicine. Dr. Windebank says, “The opportunity to work together with a multidisciplinary, multi-institutional team that will create new therapies for our injured service members is a privilege, and we are proud that Mayo Clinic will be able to make a contribution to this effort.”

Other organizations will focus on head and face trauma, burns, transplants, and other conditions. The consortium — the Armed Forces Institute of Regenerative Medicine (AFIRM) — is part of a national effort created to address the health care challenges of severely injured veterans returning from Afghanistan and Iraq. It is funded by the Army Medical Research and Materiel Command, in conjunction with the Office of Naval Research and the National Institutes of Health.

Read news release.

Journalists: Sound bites with Dr. Windebank are available in the downloads.





Please login or become a member to post a comment.